ArticleNPJ breast cancer2024

Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy.

Tomás Pascual et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.